Mangala V. Hegde

Guwahati, AS 781039, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Reprogramming Tumorigenesis and the Tumor Microenvironment with Flavokawains.

Reprogramming Tumorigenesis and the Tumor Microenvironment with Flavokawains.

Journal: Cancers
Published: May 14, 2026

Molecular insights into the anti-COVID-19 activity of reduced (quinol) and oxidized (quinone) forms of coenzyme Q10.

Molecular insights into the anti-COVID-19 activity of reduced (quinol) and oxidized (quinone) forms of coenzyme Q10.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 09, 2026

Non-Coding RNA-GATA Axis: Mechanisms and Implications in Cancer Progression and Metastases.

Non-Coding RNA-GATA Axis: Mechanisms and Implications in Cancer Progression and Metastases.

Journal: Cancers
Published: November 02, 2025

Kavain for health promotion and disease mitigation: Pharmacological promise and therapeutic perspectives.

Kavain for health promotion and disease mitigation: Pharmacological promise and therapeutic perspectives.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 26, 2025

Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling.

Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling.

Journal: Cancers
Published: July 03, 2025

Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition.

Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 12, 2025

Restoring FXR expression as a novel treatment strategy in liver cancer and other liver disorders.

Restoring FXR expression as a novel treatment strategy in liver cancer and other liver disorders.

Journal: Expert opinion on therapeutic targets
Published: April 01, 2025

Comprehensive big data analysis reveals SLC10A3 as a potential biomarker in head and neck cancer.

Comprehensive big data analysis reveals SLC10A3 as a potential biomarker in head and neck cancer.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 20, 2025

Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence.

Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence.

Journal: Journal of biochemical and molecular toxicology
Published: March 13, 2025

Bioresponsive engineered nanoparticles for immunomodulation.

Bioresponsive engineered nanoparticles for immunomodulation.

Journal: BMC medicine
Published: January 21, 2025

Protein iron transporters as potential therapeutic targets in cancer: A review.

Protein iron transporters as potential therapeutic targets in cancer: A review.

Journal: International journal of biological macromolecules
Published: January 06, 2025

Exosomal dynamics: Bridging the gap between cellular senescence and cancer therapy.

Exosomal dynamics: Bridging the gap between cellular senescence and cancer therapy.

Journal: Mechanisms of ageing and development
Published: November 28, 2024
Showing 1-12 of 51

Last Updated: 09/26/2026